Transvaginal dehydroepiandrosterone: an unconventional proposal to deliver a mysterious androgen that has no receptor or target tissue using a strategy with a new name: hormone precursor replacement therapy (HPRT).
Buster
John E
JE
D000282:Administration, Intravaginal; D001284:Atrophy; D017326:Clinical Trials, Phase III as Topic; D003687:Dehydroepiandrosterone / Q000172:deficiency* / Q000378:metabolism / Q000627:therapeutic use*; D005260:Female; D020249:Hormone Replacement Therapy / Q000379:methods*; D006801:Humans; D008875:Middle Aged; D017698:Postmenopause / Q000187:drug effects* / Q000502:physiology; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy / Q000209:etiology; D014621:Vagina / Q000187:drug effects / Q000473:pathology; D015385:Zona Reticularis / Q000187:drug effects / Q000502:physiology
D003687:Dehydroepiandrosterone